Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump )
Also on site :
- How Trump’s trillions in new tariffs could affect America — and you
- Notice of 2025 Annual General Meeting and 2024 Annual Report and Accounts
- Not Even a Royal Invite Spared the U.K. From Trump’s Tariffs